Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development

Ashot Avagimyan, Tamuna Gvianishvili, Liana Gogiashvili, Lev Kakturskiy, Nizal Sarrafzadegan, Artashes Aznauryan

Open source

DOI
10.1016/j.cpcardiol.2021.101051
Published
2023-03
Container
Current Problems in Cardiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cpcardiol.2021.101051,
  title = {Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development},
  author = {Ashot Avagimyan and Tamuna Gvianishvili and Liana Gogiashvili and Lev Kakturskiy and Nizal Sarrafzadegan and Artashes Aznauryan},
  year = {2023},
  journal = {Current Problems in Cardiology},
  doi = {10.1016/j.cpcardiol.2021.101051},
  url = {https://doi.org/10.1016/j.cpcardiol.2021.101051}
}

RIS

TY  - JOUR
TI  - Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development
AU  - Ashot Avagimyan
AU  - Tamuna Gvianishvili
AU  - Liana Gogiashvili
AU  - Lev Kakturskiy
AU  - Nizal Sarrafzadegan
AU  - Artashes Aznauryan
PY  - 2023
JO  - Current Problems in Cardiology
DO  - 10.1016/j.cpcardiol.2021.101051
UR  - https://doi.org/10.1016/j.cpcardiol.2021.101051
ER  - 

APA

Avagimyan, A., Gvianishvili, T., Gogiashvili, L., Kakturskiy, L., Sarrafzadegan, N., & Aznauryan, A. (2023). Chemotherapy, hypothyroidism and oral dysbiosis as a novel risk factor of cardiovascular pathology development. Current Problems in Cardiology. https://doi.org/10.1016/j.cpcardiol.2021.101051

Source records